+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astrazeneca PLC - logo
Social Responsibility Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Social Responsibility Trends in Healthcare - Thematic Intelligence

  • Report
  • March 2023
  • 54 Pages
  • Global
From
Corporate Governance Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Corporate Governance Trends in Healthcare - Thematic Intelligence

  • Report
  • February 2023
  • 55 Pages
  • Global
From
Environmental Trends in Healthcare - Thematic Intelligence - Product Thumbnail Image

Environmental Trends in Healthcare - Thematic Intelligence

  • Report
  • January 2023
  • 57 Pages
  • Global
From
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase - Product Thumbnail Image

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase

  • Drug Pipelines
  • October 2018
  • 98 Pages
  • Global
From
Seasonal Influenza Vaccines: Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Seasonal Influenza Vaccines: Forecast in Asia-Pacific Markets to 2028

  • Report
  • December 2019
  • 104 Pages
  • Asia Pacific
From
Heart Failure: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Heart Failure: Global Drug Forecast and Market Analysis to 2028

  • Report
  • December 2019
  • 190 Pages
  • Global
From
AstraZeneca PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

AstraZeneca PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • February 2026
  • 50 Pages
From
AstraZeneca Pharma India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

AstraZeneca Pharma India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • February 2026
  • 50 Pages
  • India
From
2024 AstraZeneca Full-Year Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

2024 AstraZeneca Full-Year Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • January 2025
  • Global
From
AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • June 2025
  • 109 Pages
From
AstraZeneca Plc - Digital Transformation Strategies - Product Thumbnail Image

AstraZeneca Plc - Digital Transformation Strategies

  • Company Profile
  • October 2023
  • 30 Pages
From
AstraZeneca PLC - Company Profile and SWOT Analysis - Product Thumbnail Image

AstraZeneca PLC - Company Profile and SWOT Analysis

  • SWOT Analysis
  • June 2025
  • 55 Pages
From
Pharmaceutical Industry in UK - Porter s Five Forces Strategy Analysis - Product Thumbnail Image

Pharmaceutical Industry in UK - Porter s Five Forces Strategy Analysis

  • Report
  • June 2018
  • 20 Pages
  • United Kingdom
From
Comprehensive Report on AstraZeneca, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on AstraZeneca, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator